Eine klinische Phase II Studie zur Induktions‐, Konsolidierungs‐ und Erhaltungstherapie mit Isatuximab, Carfilzomib, Lenalidomid und Dexamethason (I‐KRd) in der Primärtherapie des Hochrisikomyeloms

A randomised, double blind, multi-centre, placebo-controlled, parallel-ram Phase 2 Trial to assess safety, efficacy and pharmacokinetics of CD 11301 0.03% and 0.06% gel in the Treatment of Cutaneous T-Cell Lymphoma (CTCL), stages IA, IB and IIA

A Phase II, multicenter, open-Label, randomized-controlled Trial evaluating the efficacy and safety of a sequencing schedule of cobimetinib plus vemurafenib followed by immunotherapy with an anti- PD-L1 antibody atezolizumab for the Treatment in patients with unresectable or metastatic BRAF V600 Mutant melanoma ImmunoCobiVem.

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

A Phase 2 Multicenter Study Evaluating the efficacy of KTE-C19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) (ZUMA 2)

Treosulfan-based conditioning in paediatric patients with haematological malignancies

Modified FOLFOX plus/minus Nivolumab and Ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction - The randomized phase 2 MOONLIGHT trial.

Ganzhirnbestrahlung mit Hippocampusschonung und Dosiseskalation auf die Metastasen: neurokognitive Untersuchungen und biologische Bildgebung